السوق العالمية لتسلسل الجيل الثالث - اتجاهات الصناعة وتوقعاتها حتى عام 2030

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL THIRD GENERATION SEQUENCING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL THIRD GENERATION SEQUENCING MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 EPIDEMIOLOGY BASED MODELLING

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL THIRD GENERATION SEQUENCING MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER’S 5 FORCES MODEL

5.3 STRATEGIC INITIATIVES

6 REGULATORY FRAMEWORK

7 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 SEQUENCING INSTRUMENTS

7.2.1 SINGLE-MOLECULE REAL-TIME (SMRT) DEVICES

7.2.1.1. MARKET VLAUE (USD MN)

7.2.1.2. MARKET VOLUME (UNITS)

7.2.1.3. AVERAGE SELLING PRICE (USD)

7.2.2 NANOPORE SEQUENCING DEVICES

7.2.2.1. MARKET VLAUE (USD MN)

7.2.2.2. MARKET VOLUME (UNITS)

7.2.2.3. AVERAGE SELLING PRICE (USD)

7.2.3 OTHERS

7.3 CONSUMABLES

7.3.1 SEQUENCING KIT

7.3.1.1. DNA BASED

7.3.1.1.1. MARKET VLAUE (USD MN)

7.3.1.1.2. MARKET VOLUME (UNITS)

7.3.1.1.3. AVERAGE SELLING PRICE (USD)

7.3.1.2. RNA BASED

7.3.1.2.1. MARKET VLAUE (USD MN)

7.3.1.2.2. MARKET VOLUME (UNITS)

7.3.1.2.3. AVERAGE SELLING PRICE (USD)

7.3.2 LIBRARY PREPARATION KIT

7.3.2.1. MARKET VLAUE (USD MN)

7.3.2.2. MARKET VOLUME (UNITS)

7.3.2.3. AVERAGE SELLING PRICE (USD)

7.3.3 DNA BARCODING KIT

7.3.3.1. BARCODING PRIMER

7.3.3.1.1. MARKET VLAUE (USD MN)

7.3.3.1.2. MARKET VOLUME (UNITS)

7.3.3.1.3. AVERAGE SELLING PRICE (USD)

7.3.3.2. BARCODING ADAPTERS

7.3.3.2.1. MARKET VLAUE (USD MN)

7.3.3.2.2. MARKET VOLUME (UNITS)

7.3.3.2.3. AVERAGE SELLING PRICE (USD)

7.3.3.3. OTHERS

7.3.4 DNA ACCESSORY

7.3.4.1. MIXING PLATES

7.3.4.1.1. MARKET VLAUE (USD MN)

7.3.4.1.2. MARKET VOLUME (UNITS)

7.3.4.1.3. AVERAGE SELLING PRICE (USD)

7.3.4.2. SAMPLE PLATES

7.3.4.2.1. MARKET VLAUE (USD MN)

7.3.4.2.2. MARKET VOLUME (UNITS)

7.3.4.2.3. AVERAGE SELLING PRICE (USD)

7.3.4.3. PIPETTE TIPS

7.3.4.3.1. MARKET VLAUE (USD MN)

7.3.4.3.2. MARKET VOLUME (UNITS)

7.3.4.3.3. AVERAGE SELLING PRICE (USD)

7.3.4.4. TUBE SEPTA

7.3.4.4.1. MARKET VLAUE (USD MN)

7.3.4.4.2. MARKET VOLUME (UNITS)

7.3.4.4.3. AVERAGE SELLING PRICE (USD)

7.3.4.5. OTHERS

7.3.5 BINDING AND CLEANUP KIT

7.3.5.1. INTERNAL CONTROL KITS

7.3.5.1.1. MARKET VLAUE (USD MN)

7.3.5.1.2. MARKET VOLUME (UNITS)

7.3.5.1.3. AVERAGE SELLING PRICE (USD)

7.3.5.2. LOADING CLEAN UP BEAD KIT

7.3.5.2.1. MARKET VLAUE (USD MN)

7.3.5.2.2. MARKET VOLUME (UNITS)

7.3.5.2.3. AVERAGE SELLING PRICE (USD)

7.3.5.3. BINDING BUFFER KIT

7.3.5.3.1. MARKET VLAUE (USD MN)

7.3.5.3.2. MARKET VOLUME (UNITS)

7.3.5.3.3. AVERAGE SELLING PRICE (USD)

7.3.5.4. OTHERS

7.3.6 OTHERS

7.4 SEQUENCING AS SERVICES

7.4.1 MARKET VLAUE (USD MN)

7.4.2 MARKET VOLUME (UNITS)

7.4.3 AVERAGE SELLING PRICE (USD)

7.5 SUPPORTING HARDWARE

7.5.1 MARKET VLAUE (USD MN)

7.5.2 MARKET VOLUME (UNITS)

7.5.3 AVERAGE SELLING PRICE (USD)

8 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING (LONG READ)

8.2.1 BY PRODUCT

8.2.1.1. SEQUENCING INSTRUMENTS

8.2.1.2. CONSUMABLES

8.2.1.3. SEQUENCING AS SERVICE

8.2.1.4. SUPPORTIVE HARDWARE

8.2.2 BY USAGE

8.2.2.1. CLINICAL

8.2.2.2. RESEARCH

8.2.3 BY TYPE OF NUCLEOTIDE SEQUENCES

8.2.3.1. RNA

8.2.3.2. DNA

8.3 NANOPORE-BASED SINGLE MOLECULE ANALYSIS TECHNOLOGY (DIRECT LONG READ)

8.3.1 BY PRODUCT

8.3.1.1. SEQUENCING INSTRUMENTS

8.3.1.2. CONSUMABLES

8.3.1.3. SEQUENCING AS SERVICE

8.3.1.4. SUPPORTIVE HARDWARE

8.3.2 BY USAGE

8.3.2.1. CLINICAL

8.3.2.2. RESEARCH

8.3.3 BY TYPE

8.3.3.1. SOLID STATE

8.3.3.2. BIOLOGICAL

8.3.3.3. HYBRID

8.3.4 BY TYPE OF NUCLEOTIDE SEQUENCES

8.3.4.1. RNA

8.3.4.2. DNA

8.4 SINGLE MOLECULE SEQUENCING (SHORT READ)

8.4.1 BY PRODUCT

8.4.1.1. SEQUENCING INSTRUMENTS

8.4.1.2. CONSUMABLES

8.4.1.3. SEQUENCING AS SERVICE

8.4.1.4. SUPPORTIVE HARDWARE

8.4.2 BY USAGE

8.4.2.1. CLINICAL

8.4.2.2. RESEARCH

8.4.3 BY TYPE OF NUCLEOTIDE SEQUENCES

8.4.3.1. RNA

8.4.3.2. DNA

9 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY METHODS

9.1 OVERVIEW

9.2 WHOLE GENOME SEQUENCING

9.3 METAGENOME SEQUENCING

9.4 RNA SEQUENCING

9.5 EPIGENETICS

9.6 TARGETED SEQUENCING

10 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 CLINICAL

10.2.1 CLINICAL DIAGNOSTIC

10.2.1.1. RARE DISEASE DIAGNOSIS

10.2.1.2. INFECTIOUS DISEASE DIAGNOSIS

10.2.1.3. CANCER DIAGNOSIS

10.2.1.4. OTHERS

10.2.2 FORENSIC

10.2.3 RETYPEIVE HEALTH

10.2.4 PRENATAL TESTING

10.2.5 OTHERS

10.3 RESEARCH

10.3.1 EPIGENETICS

10.3.1.1. HUMAN AND EUKARYOTE EPIGENETICS

10.3.1.2. MICROBIAL EPIGENETICS

10.3.2 DRUG DISCOVERY

10.3.2.1. ONCLOLOGY

10.3.2.2. RARE DISEASES

10.3.2.3. GENETIC DISORDERS

10.3.2.4. OTHERS

10.3.3 METAGENOMICS

10.3.4 OTHERS

11 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY WORK FLOW

11.1 OVERVIEW

11.2 LIBRARY PREPARATION

11.3 SEQUENCING

11.4 DATA ANALYSIS

11.5 OTHERS

12 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY TYPE OF NUCLEOTIDE SEQUENCES

12.1 OVERVIEW

12.2 DNA

12.3 RNA

13 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITALS

13.3 ACADEMIC & RESEARCH INSTITUTES

13.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIESS

13.5 CLINICAL AND DIAGNOSTIC LABORATORIES

13.6 OTHERS

14 U.S. DENTAL DEVICES AND CONSUMABLES MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDERS

14.3 RETAIL SALES

14.4 OTHERS

15 GLOBAL THIRD GENERATION SEQUENCING MARKET, BY REGION

15.1 GLOBAL THIRD GENERATION SEQUENCING MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

15.2 NORTH AMERICA

15.2.1 U.S.

15.2.1.1. U.S THIRD GENERATION SEQUENCING MARKET, BY PRODUCT

15.2.1.2. U.S THIRD GENERATION SEQUENCING MARKET, BY TECHNOLOGY

15.2.1.3. U.S THIRD GENERATION SEQUENCING MARKET, BY METHODS

15.2.1.4. U.S THIRD GENERATION SEQUENCING MARKET, BY WORKFLOW

15.2.1.5. U.S THIRD GENERATION SEQUENCING MARKET, BY TYPE OF NUCLEOTIDE SEQUENCED

15.2.1.6. U.S THIRD GENERATION SEQUENCING MARKET, BY APPLICATIONS

15.2.1.7. U.S THIRD GENERATION SEQUENCING MARKET, BY END USER

15.2.1.8. U.S THIRD GENERATION SEQUENCING MARKET, BY DISTRIBUTION CHANNELS

15.2.2 CANADA

15.2.3 MEXICO

15.3 EUROPE

15.3.1 GERMANY

15.3.2 FRANCE

15.3.3 U.K.

15.3.4 FINLAND

15.3.5 DENMARK

15.3.6 NORWAY

15.3.7 POLAND

15.3.8 ITALY

15.3.9 SPAIN

15.3.10 RUSSIA

15.3.11 TURKEY

15.3.12 BELGIUM

15.3.13 NETHERLANDS

15.3.14 SWITZERLAND

15.3.15 SWEDEN

15.3.16 REST OF EUROPE

15.4 ASIA-PACIFIC

15.4.1 JAPAN

15.4.2 CHINA

15.4.3 SOUTH KOREA

15.4.4 INDIA

15.4.5 SINGAPORE

15.4.6 THAILAND

15.4.7 INDONESIA

15.4.8 MALAYSIA

15.4.9 PHILIPPINES

15.4.10 AUSTRALIA

15.4.11 NEW ZEALAND

15.4.12 VIETNAM

15.4.13 TAIWAN

15.4.14 REST OF ASIA-PACIFIC

15.4.15

15.5 SOUTH AMERICA

15.5.1 BRZIL

15.5.2 ARGENTINA

15.5.3 REST OF SOUTH AMERICA

15.6 MIDDLE EAST AND AFRICA

15.6.1 SOUTH AFRICA

15.6.2 SAUDI ARABIA

15.6.3 UAE

15.6.4 EGYPT

15.6.5 KUWAIT

15.6.6 OMAN

15.6.7 ISRAEL

15.6.8 BAHRAIN

15.6.9 REST OF MIDDLE EAST AND AFRICA

15.6.10 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

16 GLOBAL THIRD GENERATION SEQUENCING MARKET, SWOT AND DBMR ANALYSIS

17 GLOBAL THIRD GENERATION SEQUENCING MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.3 COMPANY SHARE ANALYSIS: EUROPE

17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17.5 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

17.6 COMPANY SHARE ANALYSIS: SOUTH AMERICA

17.7 MERGERS & ACQUISITIONS

17.8 NEW PRODUCT DEVELOPMENT & APPROVALS

17.9 EXPANSIONS

17.1 REGULATORY CHANGES

17.11 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

18 GLOBAL THIRD GENERATION SEQUENCING MARKET, COMPANY PROFILE

18.1 PACIFIC BIOSCIENCES OF CALIFOENICA INC

18.1.1 COMPANY OVERVIEW

18.1.2 REVENUE ANALYSIS

18.1.3 GEOGRAPHIC PRESENCE

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 ILLUMINA

18.2.1 COMPANY OVERVIEW

18.2.2 REVENUE ANALYSIS

18.2.3 GEOGRAPHIC PRESENCE

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.3 OXFORD NANAOPORE TECHNOLOGIES

18.3.1 COMPANY OVERVIEW

18.3.2 REVENUE ANALYSIS

18.3.3 GEOGRAPHIC PRESENCE

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 GENXONE S.A

18.4.1 COMPANY OVERVIEW

18.4.2 REVENUE ANALYSIS

18.4.3 GEOGRAPHIC PRESENCE

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 F- HOFFMANN LA ROCHE

18.5.1 COMPANY OVERVIEW

18.5.2 REVENUE ANALYSIS

18.5.3 GEOGRAPHIC PRESENCE

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 QUANTAPORE

18.6.1 COMPANY OVERVIEW

18.6.2 REVENUE ANALYSIS

18.6.3 GEOGRAPHIC PRESENCE

18.6.4 PRODUCT PORTFOLIO

18.6.5 RECENT DEVELOPMENTS

18.7 FG TECHNOLOGIES

18.7.1 COMPANY OVERVIEW

18.7.2 REVENUE ANALYSIS

18.7.3 GEOGRAPHIC PRESENCE

18.7.4 PRODUCT PORTFOLIO

18.7.5 RECENT DEVELOPMENTS

18.8 BASECLEAR B.V

18.8.1 COMPANY OVERVIEW

18.8.2 REVENUE ANALYSIS

18.8.3 GEOGRAPHIC PRESENCE

18.8.4 PRODUCT PORTFOLIO

18.8.5 RECENT DEVELOPMENTS

18.9 GARVAN INSTITUTE

18.9.1 COMPANY OVERVIEW

18.9.2 REVENUE ANALYSIS

18.9.3 GEOGRAPHIC PRESENCE

18.9.4 PRODUCT PORTFOLIO

18.9.5 RECENT DEVELOPMENTS

18.1 THERMOFISHER SCIENTIFIC INC

18.10.1 COMPANY OVERVIEW

18.10.2 REVENUE ANALYSIS

18.10.3 GEOGRAPHIC PRESENCE

18.10.4 PRODUCT PORTFOLIO

18.10.5 RECENT DEVELOPMENTS

18.11 PERKIN ELMER INC

18.11.1 COMPANY OVERVIEW

18.11.2 REVENUE ANALYSIS

18.11.3 GEOGRAPHIC PRESENCE

18.11.4 PRODUCT PORTFOLIO

18.11.5 RECENT DEVELOPMENTS

18.12 NOVOGENE CORPORATION

18.12.1 COMPANY OVERVIEW

18.12.2 REVENUE ANALYSIS

18.12.3 GEOGRAPHIC PRESENCE

18.12.4 PRODUCT PORTFOLIO

18.12.5 RECENT DEVELOPMENTS

18.13 GENEWIZ INC

18.13.1 COMPANY OVERVIEW

18.13.2 REVENUE ANALYSIS

18.13.3 GEOGRAPHIC PRESENCE

18.13.4 PRODUCT PORTFOLIO

18.13.5 RECENT DEVELOPMENTS

18.14 LEXOGEN GMBH

18.14.1 COMPANY OVERVIEW

18.14.2 REVENUE ANALYSIS

18.14.3 GEOGRAPHIC PRESENCE

18.14.4 PRODUCT PORTFOLIO

18.14.5 RECENT DEVELOPMENTS

18.15 MACROGEN INC

18.15.1 COMPANY OVERVIEW

18.15.2 REVENUE ANALYSIS

18.15.3 GEOGRAPHIC PRESENCE

18.15.4 PRODUCT PORTFOLIO

18.15.5 RECENT DEVELOPMENTS

18.16 PROMEGA CORPORATION

18.16.1 COMPANY OVERVIEW

18.16.2 REVENUE ANALYSIS

18.16.3 GEOGRAPHIC PRESENCE

18.16.4 PRODUCT PORTFOLIO

18.16.5 RECENT DEVELOPMENTS

18.17 DNA TECHNOLOGIES CORE

18.17.1 COMPANY OVERVIEW

18.17.2 REVENUE ANALYSIS

18.17.3 GEOGRAPHIC PRESENCE

18.17.4 PRODUCT PORTFOLIO

18.17.5 RECENT DEVELOPMENTS

18.18 TATAA BIOCENTER

18.18.1 COMPANY OVERVIEW

18.18.2 REVENUE ANALYSIS

18.18.3 GEOGRAPHIC PRESENCE

18.18.4 PRODUCT PORTFOLIO

18.18.5 RECENT DEVELOPMENTS

18.19 UNIVERSAL SEQUENCING TECHNOLOGY

18.19.1 COMPANY OVERVIEW

18.19.2 REVENUE ANALYSIS

18.19.3 GEOGRAPHIC PRESENCE

18.19.4 PRODUCT PORTFOLIO

18.19.5 RECENT DEVELOPMENTS

*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

19 RELATED REPORTS

20 CONCLUSION

21 QUESTIONNAIRE

22 ABOUT DATA BRIDGE MARKET RESEARCH